QNRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Quoin Pharmaceuticals Ltd (QNRX).


$3.29M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

QNRX Market Cap. (MRY)


QNRX Shares Outstanding (MRY)


QNRX Assets (MRY)


Total Assets

$15.71M

Total Liabilities

$6.50M

Total Investments

$10.43M

QNRX Income (MRY)


Revenue

$0

Net Income

-$8.96M

Operating Expense

$9.53M

QNRX Cash Flow (MRY)


CF Operations

-$7.86M

CF Investing

-$1.89M

CF Financing

$10.97M

QNRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

-

-

2023

$0

0%

0%

-

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

QNRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$15,709,338 (29.09%)

$12,169,229 (-15.83%)

$14,458,063 (54.52%)

$9,356,851 (579.11%)

Assets Current

$14,926,004 (32.25%)

$11,285,895 (-15.59%)

$13,370,112 (63.09%)

$8,198,247 (1662.42%)

Assets Non-Current

$783,334 (-11.32%)

$883,334 (-18.81%)

$1,087,951 (-6.10%)

$1,158,604 (26.95%)

Goodwill & Intangible Assets

$483,334 (-17.14%)

$583,334 (-17.21%)

$704,561 (-12.87%)

$808,604 (-11.40%)

Shareholders Equity

$9,204,673 (62.51%)

$5,664,016 (-23.53%)

$7,406,774 (1027.31%)

$657,032 (109.94%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$3,623,343 (50.90%)

$2,401,198 (-16.06%)

$2,860,628 (-61.77%)

$7,482,773 (2210.70%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$10,433,535 (25.80%)

$8,293,663 (-17.00%)

$9,992,900 (0%)

$0 (0%)

Investments Current

$10,433,535 (25.80%)

$8,293,663 (-17.00%)

$9,992,900 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$905,704 (72.02%)

$526,523 (-13.06%)

$605,600 (-34.40%)

$923,239 (-81.12%)

Accumulated Retained Earnings (Deficit)

-$55,165,792 (-19.40%)

-$46,203,320 (-23.15%)

-$37,516,747 (-33.65%)

-$28,069,985 (-324.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$6,504,665 (-0.01%)

$6,505,213 (-7.74%)

$7,051,289 (-18.95%)

$8,699,819 (8.95%)

Liabilities Current

$4,180,932 (16.74%)

$3,581,480 (1.53%)

$3,527,556 (-22.91%)

$4,576,087 (-42.69%)

Liabilities Non-Current

$2,323,733 (-20.52%)

$2,923,733 (-17.03%)

$3,523,733 (-14.55%)

$4,123,732 (0%)

QNRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$5,925,833 (-2.38%)

$6,070,517 (-7.81%)

$6,584,868 (46.33%)

$4,499,923 (215.59%)

Research & Development Expense

$3,602,632 (8.91%)

$3,307,987 (23.76%)

$2,672,836 (71.01%)

$1,562,927 (540.14%)

Operating Expenses

$9,528,465 (1.60%)

$9,378,504 (1.30%)

$9,257,704 (52.70%)

$6,062,850 (263.04%)

Interest Expense

$0 (0%)

$0 (0%)

$714,081 (-47.70%)

$1,365,409 (2803.83%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$8,962,472 (-3.18%)

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$8,962,472 (-3.18%)

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$8,962,472 (-3.18%)

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

Weighted Average Shares

$5,049,720 (411.51%)

$987,220 (144.43%)

$403,884 (1434.69%)

$26,317 (31.43%)

Weighted Average Shares Diluted

-

-

-

$26,317 (31.43%)

Earning Before Interest & Taxes (EBIT)

-$8,962,472 (-3.18%)

-$8,686,573 (-0.22%)

-$8,667,415 (56.87%)

-$20,097,179 (-881.14%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$9,528,465 (-1.60%)

-$9,378,504 (-1.30%)

-$9,257,704 (-52.70%)

-$6,062,850 (-263.04%)

QNRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,888,282 (-186.29%)

$2,188,316 (121.56%)

-$10,149,121 (-1523.86%)

-$625,000 (-400.00%)

Net Cash Flow from Financing

$10,967,736 (110.24%)

$5,216,683 (-62.76%)

$14,007,708 (3.73%)

$13,504,031 (655.49%)

Net Cash Flow from Operations

-$7,857,309 (0.09%)

-$7,864,429 (7.27%)

-$8,480,732 (-48.26%)

-$5,720,090 (-327.31%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,222,145 (366.01%)

-$459,430 (90.06%)

-$4,622,145 (-164.56%)

$7,158,941 (2110.70%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$1,888,282 (-186.29%)

$2,188,316 (122.11%)

-$9,899,121 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$250,000 (60.00%)

-$625,000 (-400.00%)

Issuance (Repayment) of Debt Securities

-$600,000 (5.15%)

-$632,583 (30.61%)

-$911,669 (-128.75%)

$3,170,534 (268.68%)

Issuance (Purchase) of Equity Shares

$11,567,736 (97.76%)

$5,849,266 (-60.68%)

$14,877,332 (47.26%)

$10,102,874 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,258,890 (15.01%)

$1,094,549 (43.26%)

$764,007 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$100,000 (-3.57%)

$103,706 (-0.32%)

$104,043 (0.00%)

$104,043 (0.00%)

QNRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-114.70% (-9.13%)

-105.10% (64.49%)

-296.00% (-141.03%)

721.40% (1216.72%)

Return on Average Assets (ROAA)

-62.60% (-12.39%)

-55.70% (37.56%)

-89.20% (77.69%)

-399.90% (-1141.93%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-128.30% (-8.64%)

-118.10% (70.33%)

-398.00% (-200.40%)

396.40% (186.83%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-

-

-

-0.46 (-1367.74%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.36 (-58.25%)

0.85 (-7.97%)

0.93 (-95.98%)

23.13 (1909.86%)

Debt to Equity Ratio (D/E)

0.71 (-38.47%)

1.15 (20.69%)

0.95 (-92.81%)

13.24 (1195.20%)

Earnings Per Share (EPS)

-

-

-

-600 (98.57%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.56 (80.47%)

-7.97 (63.15%)

-21.62 (91.03%)

-241.1 (-229.86%)

Book Value Per Share (BVPS)

1.82 (-68.22%)

5.74 (-68.72%)

18.34 (-26.54%)

24.97 (107.57%)

Tangible Assets Book Value Per Share (TABVPS)

3.02 (-74.31%)

11.74 (-65.54%)

34.05 (-89.52%)

324.82 (1298.28%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-1 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.02 (90.31%)

-0.2 (-2.62%)

-0.19 (81.60%)

-1.04 (10.75%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.57 (13.30%)

3.15 (-16.86%)

3.79 (111.50%)

1.79 (2989.66%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,857,309 (0.09%)

-$7,864,429 (9.92%)

-$8,730,732 (-37.60%)

-$6,345,090 (-333.52%)

Enterprise Value (EV)

$169,103 (-89.93%)

$1,678,888 (2.85%)

$1,632,376 (-92.14%)

$20,757,585 (818.10%)

Earnings Before Tax (EBT)

-$8,962,472 (-3.18%)

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$8,862,472 (-3.26%)

-$8,582,867 (-0.23%)

-$8,563,372 (57.17%)

-$19,993,136 (-928.29%)

Invested Capital

$7,421,729 (32.45%)

$5,603,217 (-23.92%)

$7,365,318 (309.80%)

-$3,510,613 (47.05%)

Working Capital

$10,745,072 (39.47%)

$7,704,415 (-21.72%)

$9,842,556 (171.73%)

$3,622,160 (148.17%)

Tangible Asset Value

$15,226,004 (31.42%)

$11,585,895 (-15.76%)

$13,753,502 (60.89%)

$8,548,247 (1737.66%)

Market Capitalization

$3,285,853 (-32.14%)

$4,842,314 (-29.64%)

$6,882,208 (-54.71%)

$15,197,064 (79.96%)

Average Equity

$7,812,553 (-5.49%)

$8,266,007 (160.82%)

$3,169,230 (206.52%)

-$2,975,132 (-191.69%)

Average Assets

$14,319,080 (-8.21%)

$15,599,314 (48.39%)

$10,512,215 (95.86%)

$5,367,334 (-17.61%)

Invested Capital Average

$6,985,766 (-5.03%)

$7,355,600 (237.80%)

$2,177,505 (142.94%)

-$5,070,538 (-242.18%)

Shares

5,049,720 (411.51%)

987,220 (144.43%)

403,884 (625.54%)

55,667 (754.31%)